Global Medical REIT Inc. (GMRE)
NYSE: GMRE · Real-Time Price · USD
8.89
+0.10 (1.14%)
At close: Nov 13, 2024, 4:00 PM
8.98
+0.09 (1.01%)
Pre-market: Nov 14, 2024, 8:00 AM EST
Global Medical REIT Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Global Medical REIT stock have an average target of 10.88, with a low estimate of 10 and a high estimate of 11.75. The average target predicts an increase of 22.38% from the current stock price of 8.89.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for GMRE stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Berenberg | Berenberg | Strong Buy Initiates $12 | Strong Buy | Initiates | $12 | +32.17% | Oct 18, 2024 |
| B. Riley Securities | B. Riley Securities | Strong Buy Maintains $11 → $10 | Strong Buy | Maintains | $11 → $10 | +12.49% | May 13, 2024 |
| B. Riley Securities | B. Riley Securities | Strong Buy Maintains $12 → $11 | Strong Buy | Maintains | $12 → $11 | +23.73% | May 8, 2023 |
| B. Riley Securities | B. Riley Securities | Strong Buy Maintains $14 → $12 | Strong Buy | Maintains | $14 → $12 | +34.98% | Mar 6, 2023 |
| Baird | Baird | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Oct 10, 2022 |
Financial Forecast
Revenue This Year
141.91M
Revenue Next Year
148.66M
from 141.91M
Increased by 4.76%
EPS This Year
n/a
from 0.23
EPS Next Year
0.08
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 146.9M | 161.2M | 168.8M |
| Avg | 141.9M | 148.7M | 154.2M |
| Low | 135.0M | 137.1M | 140.1M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | 13.6% | 13.6% |
| Avg | - | 4.8% | 3.7% |
| Low | - | -3.4% | -5.8% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 0.02 | 0.11 | 0.07 |
| Avg | - | 0.08 | 0.07 |
| Low | -0.02 | 0.04 | 0.07 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -90.7% | - | -6.0% |
| Avg | - | - | -8.7% |
| Low | - | - | -12.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.